儿童 2019 新型冠状病毒感染所致呼吸道感染的诊断与治疗建议。
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.
机构信息
Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, 310052, China.
出版信息
World J Pediatr. 2020 Jun;16(3):240-246. doi: 10.1007/s12519-020-00345-5. Epub 2020 Feb 5.
Abstract
Since December 2019, an epidemic caused by novel coronavirus (2019-nCoV) infection has occurred unexpectedly in China. As of 8 pm, 31 January 2020, more than 20 pediatric cases have been reported in China. Of these cases, ten patients were identified in Zhejiang Province, with an age of onset ranging from 112 days to 17 years. Following the latest National recommendations for diagnosis and treatment of pneumonia caused by 2019-nCoV (the 4th edition) and current status of clinical practice in Zhejiang Province, recommendations for the diagnosis and treatment of respiratory infection caused by 2019-nCoV for children were drafted by the National Clinical Research Center for Child Health, the National Children's Regional Medical Center, Children's Hospital, Zhejiang University School of Medicine to further standardize the protocol for diagnosis and treatment of respiratory infection in children caused by 2019-nCoV.
摘要
自 2019 年 12 月以来，中国发生了由新型冠状病毒（2019-nCoV）感染引起的意外疫情。截至 2020 年 1 月 31 日 20 时，中国已报告超过 20 例儿科病例。其中，浙江有 10 例患者，发病年龄从 112 天至 17 岁不等。根据最新的《国家新型冠状病毒肺炎诊疗方案（试行第四版）》和浙江省目前的临床实践情况，由国家儿童健康临床医学研究中心、国家儿童区域医疗中心、浙江大学医学院附属儿童医院制定了《儿童 2019 新型冠状病毒感染诊断、治疗和预防专家共识》，以进一步规范儿童 2019 新型冠状病毒感染所致呼吸道感染的诊治方案。
相似文献
1
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.儿童 2019 新型冠状病毒感染所致呼吸道感染的诊断与治疗建议。
World J Pediatr. 2020 Jun;16(3):240-246. doi: 10.1007/s12519-020-00345-5. Epub 2020 Feb 5.
2
[Investigation of pathogenic agents causing acute respiratory tract infections in pediatric patients in a children's hospital assigned for case screening in Beijing during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间北京某儿童医院儿科急性呼吸道感染病原筛查]
Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):635-639. doi: 10.3760/cma.j.cn112140-20200426-00437.
3
Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures.COVID-19 感染患者在急诊手术期间的麻醉管理。
J Cardiothorac Vasc Anesth. 2020 May;34(5):1125-1131. doi: 10.1053/j.jvca.2020.02.039. Epub 2020 Feb 28.
4
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.肝移植术后 COVID-19 患者的管理：北京肝移植工作组。
Hepatol Int. 2020 Jul;14(4):432-436. doi: 10.1007/s12072-020-10043-z. Epub 2020 Apr 10.
5
The First Pediatric Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Risk of Co-Infection with Other Respiratory Viruses.日本首例儿童 2019 冠状病毒病（COVID-19）患者：与其他呼吸道病毒共同感染的风险。
Jpn J Infect Dis. 2020 Sep 24;73(5):377-380. doi: 10.7883/yoken.JJID.2020.181. Epub 2020 May 29.
6
Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022.2019 年至 2022 年中国大样本研究：COVID-19 大流行前后下呼吸道感染儿童肺炎支原体检测。
BMC Infect Dis. 2024 Jun 1;24(1):549. doi: 10.1186/s12879-024-09438-2.
7
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.检测和分析 COVID-19 患者各种生物样本中的核酸。
Travel Med Infect Dis. 2020 Sep-Oct;37:101673. doi: 10.1016/j.tmaid.2020.101673. Epub 2020 Apr 18.
8
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.儿童 SARS-CoV-2 感染诊断和治疗建议更新。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2211-2223. doi: 10.1007/s10096-020-03973-x. Epub 2020 Aug 6.
9
Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection.2019 年冠状病毒感染疫情中枢地区神经外科手术实践的初步建议。
Curr Med Sci. 2020 Apr;40(2):281-284. doi: 10.1007/s11596-020-2173-5. Epub 2020 Mar 26.
10
Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China.中国浙江省 2019 年新型冠状病毒肺炎的临床特征。
Mol Med Rep. 2020 Sep;22(3):2583-2587. doi: 10.3892/mmr.2020.11329. Epub 2020 Jul 10.
引用本文的文献
1
Detection of Microorganisms Causing Human Respiratory Infection Using One-Tube Multiplex PCR.使用单管多重PCR检测引起人类呼吸道感染的微生物
Infect Dis Rep. 2025 Aug 4;17(4):93. doi: 10.3390/idr17040093.
2
Evaluation of common respiratory viruses other than SARS-CoV-2 in hospitalized children during the COVID-19 pandemic.2019冠状病毒病大流行期间住院儿童中除严重急性呼吸综合征冠状病毒2之外的常见呼吸道病毒评估
BMC Infect Dis. 2025 Jul 11;25(1):910. doi: 10.1186/s12879-025-11293-8.
3
Histopathological examination of lung from infant with lethal COVID-19 with special attention on pneumocytes type II and the immune infiltrate: a case study.对患有致命性新冠病毒病的婴儿肺部进行组织病理学检查，特别关注II型肺细胞和免疫浸润：一项病例研究。
Ital J Pediatr. 2025 Jun 7;51(1):174. doi: 10.1186/s13052-025-01984-y.
4
The impact of SARS-CoV-2 infection on immunity reconstitution among pediatric patients after allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis.严重急性呼吸综合征冠状病毒2感染对异基因造血干细胞移植后儿科患者免疫重建的影响：一项倾向评分匹配分析
Front Pediatr. 2024 Nov 21;12:1489648. doi: 10.3389/fped.2024.1489648. eCollection 2024.
5
An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future.儿童在 COVID-19 大流行期间的肺部并发症概述：未来的教训。
Immun Inflamm Dis. 2024 Nov;12(11):e70049. doi: 10.1002/iid3.70049.
6
Prevalence of Co-Infections and Pathogens in Hospitalized Children with Acute Respiratory Infections: A Comparative Analysis Between SARS-CoV-2 and Non-SARS-CoV-2 Cases.急性呼吸道感染住院儿童中合并感染及病原体的流行情况：SARS-CoV-2感染与非SARS-CoV-2感染病例的比较分析
Glob Pediatr Health. 2024 Sep 12;11:2333794X241275267. doi: 10.1177/2333794X241275267. eCollection 2024.
7
[Expert recommendations for the prevention of common respiratory viral infections in neonates].[预防新生儿常见呼吸道病毒感染的专家建议]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Aug 15;26(8):789-794. doi: 10.7499/j.issn.1008-8830.2405078.
8
Challenges of mesenchymal stem cells in the clinical treatment of COVID-19.间充质干细胞在 COVID-19 临床治疗中的挑战。
Cell Tissue Res. 2024 Jun;396(3):293-312. doi: 10.1007/s00441-024-03881-y. Epub 2024 Mar 21.
9
Profile analysis of emerging respiratory virus in children.儿童新发呼吸道病毒谱分析。
Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):873-882. doi: 10.1007/s10096-023-04615-8. Epub 2023 May 9.
10
Functional status of hospitalized pediatric patients with COVID-19 in southern Brazil: a prospective cohort study.巴西南部住院 COVID-19 儿科患者的功能状态：一项前瞻性队列研究。
J Bras Pneumol. 2023 Jan 13;48(6):e20220153. doi: 10.36416/1806-3756/e20220153. eCollection 2023.
本文引用的文献
1
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
2
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
3
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
4
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.洛匹那韦-利托那韦与干扰素-β1b联合治疗中东呼吸综合征（MIRACLE试验）：一项随机对照试验的研究方案
Trials. 2018 Jan 30;19(1):81. doi: 10.1186/s13063-017-2427-0.
5
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
6
[Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)].儿童社区获得性肺炎管理指南（2013年修订版）（一）
Zhonghua Er Ke Za Zhi. 2013 Oct;51(10):745-52.
7
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.洛匹那韦/利托那韦在严重急性呼吸综合征治疗中的作用：初步病毒学及临床研究结果
Thorax. 2004 Mar;59(3):252-6. doi: 10.1136/thorax.2003.012658.
Zotero 插件